Topic Areas
- Contraception
- Men & Fertility/Infertility
- Male Cancers
- The Male Role in Reproductive Health
- Sex, Sexuality & Sexual Health
- Men and STDs/STIs & HIV/AIDS
Genuis SJ. Are condoms the answer to rising rates of non-HIV sexually transmitted infection? No. BMJ. 2008 Jan 26; 336(7637):185.
Liu PY et al. Determinants of the rate and extent of spermatogenic suppression during hormonal male contraception: An integrated analysis. J Clin End & Metab. 2008 Feb 26.
Martino SC, Elliott MN, Collins RL, Kanouse ED, Berry SH. Virginity pledges among the willing: Delays in first intercourse and consistency of condom use. J Ado Health. 2008 June 5.
Akbal C, Türker P, Ozyürek M, et al. A New Cause of Male Infertility After Cisplatin Exposure: The Effect of Cisplatin on Y Chromosomes. Urology. 2008 Apr 11.
Antinori M et al. Intracytoplasmic morphologically selected sperm injection: A prospective randomized trial. Reprod Biomed Online. 2008 June; 16(6):835-841.
Baska KM et al. Mechanism of extracellular ubiquitination in the mammalian epididymis. J Cellular Physiology. 2007 Dec 6.
Belloc S et al. The effect of maternal and paternal age on pregnancy miscarriage rates after IUI. Reprdo Biomed Online. 2008 Jul.
Christiansen S, Scholze M, Axelstad M, Boberg J, Kortenkamp A, Hass U. Combined exposure to anti-androgens causes markedly increased frequencies of hypospadias in the rat. International J Andrology. 2008 Jan 22.
Cohen-Bacrie P, Belloc S, Menezo YJR, Clement P, Hamidi J, Benkhalifa M. Correlation between DNA damage and sperm parameters: A prospective study of 1,633 patients. Fert Stert. 2008 Apr 25.
Houshdaran S, Cortessis VK, Siegmund K, et al. Widespread epigenetic abnormalities suggest a broad DNA methylation erasure defect in abnormal human sperm. PLoS ONE; 2007 Dec 12;2(12):e1289.
Johnson PM et al. Rapid sperm acrosome reaction in the absence of acrosomal CD46 expression in promiscuous field mice (Apodemus). Reproduction. 2007 Dec; 134:739-747.
Koskimäki J, Shiri R, Tammela T, Häkkinen J, Hakama M, Auvinen A. Regular intercourse protects against erectile dysfunction: Tampere Aging Male Urologic Study. Am J Med. 2008 July; 121(7):592-596.
Kumanov P, Robeva RN, Tomova A. Adolescent varicocele: Who is at risk? Pediatrics. 2008 Jan 1; 121(1):53-57.
Nargund VH. Health issues of cycling in men. BJU Inter. 2008 June 28.
Patel SR, Sigman M. Comparison of outcomes of vasovasostomy performed in the convoluted and straight vas deferens. J Urology. 2008 Jan; 179(1):256-259.
Phillips KP, Tanphaichitr N. Human exposure to endocrine disrupters and semen quality. J Toxicol Environ Health B Crit Rev; 2008 Mar; 11(3-4):188-220.
Steinsvik EA, Fosså SD, Lilleby W, Eilertsen K. Fertility issues in patients with prostate cacner. BJU Int. 2008 May 16.
Welsh M et al. Identification in rats of a programming window for reproductive tract masculinization, disruption of which leads to hypospadias and cryptorchidism. J Clin Invest. 2008 March 13.
Yang F et al. Meiotic failure in male mice lacking an X-linked factor. Genes Dev. 2008 Mar 1; 22(5):682-691.
Young SS, Eskenazi B, Marchetti FM, Block G, Wyrobek AJ. The association of folate, zinc and antioxidant intake with sperm aneuploidy in healthy non-smoking men. Hum Reprod. 2008 Mar 19.
Abdulghani J et al. Stat3 promotes metastatic progression of prostate cancer. Am J Pathol. 2008 June; 172(6):1717-1728.
Acevedo VD et al. Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-to-mesenchymal transition. Cancer Cell. 2007 Dec 11; 12(6):559-571.
Akakura K. Significance of whole-pelvic radiotherapy for high-risk prostate cancer patients after radical prostatectomy. Future Oncol. 2007 Dec; 3(6):613-616.
Allen NE et al. Animal foods, protein, calcium and prostate cancer risk: The European prospective investigation into cancer and nutrition. Brit J Cancer. 2008; 98:1574-1581.
Antonopoulos IM et al. Radical retropubic prostatectomy for localized prostate cancer in renal transplant patients. Urology. 2008 May 14.
Bañez LL et al. Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer. JAMA. 2007 Nov; 298(19):2275-2280.
Bartsch G et al. Tyrol prostate cancer demonstration project: Early detection, treatment, outcome, incidence and mortality. BJU International. 2008 Apr; 101(7):809-816.
Beer TM et al. C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer: Results from the ASCENT trial. Cancer. 2008 Apr 21.
Beer TM et al. Intermittent chemotherapy in patients with metastatic androgen-independent prostate cancer: Results from ASCENT, a double-blinded, randomized comparison of high-dose calcitriol plus docetaxel with placebo plus docetaxel. Cancer. 2008 Jan 15; 112(2):326-330.
Beneduce L et al. Detection of prostate-specific antigen coupled to immunoglobulin M in prostate cancer patients. Cancer Detect Prev. 2007; 31(5):402-407.
Berthold DR, Pond GR, Soban F, de Wit R, Eisenberger M, Tannock IF. Docetaxel plus Prednisone or Mitoxantrone pluse Prednisone for advanced prostate cancer: Updated survival in the TAX 327 study. J Clinical Oncology. 2008 Jan 10; 26(2):242-245.
Birnie R et al. Gene expression profiling of human prostate cancer cells reveals a pro-inflammatory phenotype and the importance of extracellular matrix interactions. Genome Biol. 2008 May 20:9(5):R83.
Bong GW, Clarke Jr. HS, Hancock WC, Keane TE. Serum testosterone recovery after cessation of long-term luteinizing hormone-releasing hormone agonist in patients with prostate cacner. Urology. 2008 Feb 15.
Blana A et al. First analysis of the long-term results with Transrectal HIFU in patients with localized prostate cancer. European Urology. 2007 Nov 5.
Braithwaite RS, Concato J, Chang CC, Roberts MS, Justice AC. A framework for tailoring clinical guidelines to comorbidity at the point of care. Arch Intern Med. 2007 Nov 26; 167(21):2361-2365.
Burton JB et al. Adenovirus-mediated gene expression imaging to directly detect sentinel lymph node metastasis of prostate cancer. Nature Medicine. 2008 July 11.
Bylow K, Mohile SG, Stadler WM, Dale W. Does androgen-deprivation therapy accelerate the development of frailty in older men with prostate cancer: A conceptual review. Cancer. 2007 Dec 15; 110(12):2604-2613.
Carsten N, Pawinski A, Andratschke NH, Molls M. Does prophylactic breast irradiation in patients with prostate cancer influence cardiac toxicity? JCNI. 2007 Nov 7; 99(21):1646-1647.
Chen RC, Clark JA, Manola J, Talcott JA. Treatment ‘mismatch’ in early prostate cancer: Do treatment choices take patient quality of life into account? Cancer. 2007 Nov 26.
Choo R et al. How much does Gleason grade of follow-up biopsy differ from that of initial biopsy in untreated, Gleason score 4-7, clinically localized prostate cancer? Prosate. 2007 Nov 1; 67(15):1614-1620.
Coffey et al. Testicular microlithiasis as a familial risk factor for testicular germ cell tumour. Br J Cancer. 2007 Dec 17; 97(12):1701-1706.
Collin et al. Prostate-cancer mortality in the USA and UK in 1975-2004: An ecological study. The Lancet Oncology. 2008 Apr 16.
Cooper GS, Kou TD. Underuse of colorectal cancer screening in a cohort of medicare beneficiaries. Cancer. 2007 Dec 10.
Crook J, Fleshner N, Roberts C, Pond G. Long term urinary sequelae following 125 iodine prostate brachytherapy. J Urology. 2008 Jan; 179(1):141-146.
D’Amico AV, Renshaw AA, Loffredo B, Chen M-H. Duration of testosterone suppression and the risk of death from prostate cancer in men using radiation and 6 months of hormone therapy. Cancer. 2007 Oct 15; 110(8):1723-1728.
D’Amico AV, Chen M-H, Renshaw AA, Loffredo M, Kantoff PW. Androgen suppression and radiation vs radiation alone for prostate cancer. JAMA. 2008 Jan 23; 299(3):289-295.
Dahut WL et al. A phase II clinical trial of Sorafenib in androgen-independent prostate cancer. Clinical Cancer Research. 2008 Jan 1; 14:209-214.
Daley D et al. Identification of susceptibility genes for cancer in a genome-wide scan: Results from the colon neoplasia sibling study. Am J Human Genetics. 2008 Mar 3; 82(3):723-736.
Duggan D et al. Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. JNCI. 2007 Dec 11.
Eeles RA et al. Multiple newly identified loci associated with prostate cancer susceptibility. Nature Genetics. 2008 Feb 10; 40(2):189-197.
Efstathiou JA et al. Obesity and mortality in men with locally advanced prostate cancer. Cancer. 2007 Nov 12.
Eliaz I, Weil E, Wilk B. Integrative medicine and the role of modified citrus pectin/alginates in heavy metintegrative medicine and the role of modified citrus pectin/alginates in heavy metal chelation and detoxification-five case reports. Forschende Komplementarmedizin(Research in Complementary Medicine). 2007 Dec; 14(6):358-364.
Escudier B et al. Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: A randomized, double-blind phase III trial. The Lancet. 2007 Dec 22; 370(9605):2103-2111.
Farmer MM, Bastani R, Kwan L, Belman M, Ganz PA. Predictors of colorectal cancer screening from patients enrolled in a managed care health plan. Cancer. 2008 Feb 11.
Finley DS et al. Anatomic excision of anterior prostatic fat at radical prostatectomy: Implications for pathologic upstating. Urology. 2007 Nov; 70(5):1000-1003.
Fisher MB, Aggarwal N, Vuruskan H, Singla AK. Efficacy of artificial urinary sphincter implantation after failed bone-anchored male sling for postprostatectomy incontinence. Urology. 2007 Nov; 70(5):942-4.
Freedland SJ et al. Carbohydrate restriction, prostate cancer growth, and the insulin-like growth factor axis. Prostate. 2007 Nov 12.
Frosch DL, Bhatnagar V, Tally S, Hamori CJ, Kaplan RM. A randomized controlled trial comparing alternative approaches for men considering prostate cancer screening. Arch Intern Med. 2008 Feb 25; 168(4):363-369.
Garcia-Hernandez M, Gray A, Hubby B, Klinger OJ, Kast WM. Prostate stem cell antigen vaccination induces a long-term protective immune response against prostate cancer in the absence of autoimmunity. Cancer Research. 2008 Feb 1; 68(3):861-869.
Gilbert SM, Daignault S, Weizer AZ, Wei JT, Hollenbeck BK. The use of tumor markers in testis cancer in the United States: A potential quality issue. Urol Oncol. 2008 Mar-Apr; 26(2):153-157.
Gillis AJM et al. High-throughput microRNAome analysis in human germ cell tumours. Pathology. 2007 Nov; 213(3):319-328.
Harris AM et al. Effect of α1-adrenoceptor antagonist exposure on prostate cancer incidence: An observational cohort study. J Urology. 2007 Nov; 178(5):2176-2180.
Harvard Health Publications. Multivitamins and prostate cancer: A new worry? Harvard Men’s Health Watch Newsletter. Boston, MA; Oct 2007.
Harvard Health Publications. State-of-the-heart therapy for prostate cancer. Harvard Heart Letter. 2008 Apr 1.
Hill MM et al. PTRF-Cavin, a conserved cytoplasmic protein required for caveola formation and function. Cell. 2008 Jan 11; 132:113-124.
Jeldres C et al. High provider volume is associated with lower rate of secondary therapies after definitive radiotherapy for localized prostate cancer. Eur Urol. 2007 Nov 7.
Jørgensen KT, Pedersen BV, Johansen C, Frisch M. Fatherhood status and prostate cancer risk. Cancer. 2008 Jan 7.
Kattan MW et al. Nomogram incorporating PSA level to predict cancer-specific survival for men with clinically localized prostate cancer managed without curative intent. Cancer. 2008 Jan 1;112(1):69-74.
Kinsey T, Jemal A, Liff J, Ward E, Thun M. Secular trends in mortality from common cancers in the United States by educational attainment, 1993-2001. J Natl Cancer Inst. 2008 July; 100(14):1003-1012.
Klein EA, Kattan M, Stephenson A, Vickers A. How many lymphadenectomies does it take to cure one patient? European Urology. 2008 Jan; 53(1):13-15.
Klezovitch O et al. A causal role for ERG in neoplastic transformation of prostate epithelium. PNAS. 2008 Feb 1.
Klotz L. Low risk prostate cancer can and should often be managed with active surveillance and selective delayed intervention. Nature Clinical Practice Urology. 2008 Jan; 5(1):2-3.
Kobayashi N et al. Effect of low-fat diet on development of prostate cancer and akt phosphorylation in the hi-myc transgenic mouse model. Cancer Research. 2008 Apr 18; 68(8):3066-3073.
Krishnadasan A, Kennedy N, Zhao Y, Morgenstern H, Ritz B. Nested case-control study of occupational physical activity and prostate cancer among workers using a job exposure matrix. Cancer Causes Control. 2008 Feb; 19(1):107-114.
Kristal AR et al. Dietary patterns, supplement use and the risk of symptomatic benign prostatic hyperplasia: Results from the prostate cancer prevention trial. Am J Epidemiol. 2008 Feb 7.
Lakshman M et al. Dietary genistein inhibits metastasis of human prostate cancer in mice. Cancer Research. 2008 Mar 15; 68(6):2024-2032.
Lage MJ, Barber BL, Markus RA. Association between androgen-deprivation therapy and incidence of diabetes among males with prostate cancer. Urology. 2007 Dec; 70(6):1104-1108.
Lane JA et al. Detection of prostate cancer in unselected young men: Prospective cohort nested within a randomized controlled trial. BMJ. 2007 Nov 15.
Larson BT et al. Blood pressure surges during office-based transurethral microwave therapy for the prostate. Mayo Clin Proc. 2008 Mar; 83(3):309-312.
Laxman B et al. A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer. Cancer Research. 2008 Feb; 68(3):645-649.
Lee IH, Sadetsky N, Carroll PR, Sandler HM. The impact of treatment choice for localized prostate cancer on response to phosphodiesterase inhibitors. J Urology. 2008 Mar; 179(3):1072-1076.
Lu-Yao GL et al. Survival following primary androgen deprivation therapy among men with localized prostate cancer. JAMA. 2008 July 9; 300(2):173-181.
Madan RA et al. Analysis of overall survival in patients with nonmetastatic castration-resistant prostate cancer treated with vaccine, Nilutamide and combination therapy. Clinical Cancer Research. 2008 July 15; 14(14):4526-4531.
Magheli A, Rais-Bahrami S, Humphreys EB, Peck HJ, Trock BJ, Gonzalgo ML. Impact of patient age on biochemical recurrence rates following radical prostatectomy. J Urol. 2007 Nov; 178(5):1933-1938.
MacKenzie R, Chapman S, Barratt A, Holding S. “The news is [not] all good”: Misrepresentations and inaccuracies in Austrailian news media reports on prostate cancer screening. Med J Aust. 2007 Nov 5; 187(9):507-510.
Mattei A et al. The template of the primary lymphatic landing sites of the prostate should be revisitied: Results of a multimodality mapping study. Euro Urology. 2008 Jan; 53(1): 118-125.
McDonnell TJ et al. Biomarker expression patterns that correlate with high grade features in treatment naïve, organ-confined prostate cancer. BMC Medical Genomics. 2008 Jan 31; 1:1.
McKenna DA et al. Prostate cancer: Role of pretreatment MR in predicting outcome after external-beam radiation therapy – initial experience. Radiology. 2008 Apr; 247(1):141-146.
Mohan R. Family physicians could help in predicting life expectancy without prostate cancer. J Clin Oncol. 2008 Feb 1; 26(4):690-691.
Montgomery RB et al. Maintenance of intratumoral androgens in metastatic prostate cancer: A mechanism for castration-resistant tumor growth. Cancer Research. 2008 June 1; 68(11):447-4454.
Mossine VV, Chopra P, Mawhinney TP. Interaction of tomato lycopene and ketosamine against rat prostate tumorigenesis. Cancer Research. 2008 June 1; 68(11):4384-4391.
Murtola TJ, Tammela TL, Lahtela J, Auvinen A. Cholesterol-lowering drugs and prostate cancer risk: A population-based case-control study. Cancer Epidemiol Biomarkers Prev. 2007 Nov; 16(11):2226-32.
Myles P et al. Diagnostic radiation procedures and risk of prostate cancer. British J Cancer. 2008 Jun 3; 98(11):1852-1856.
Myrup C et al. Testicular cancer risk in first- and second-generation immigrants to Denmark. JNCI. 2007 Dec 25.
Nickel JC, Roehrborn CG, O’Leary MP, Bostwick DG, Somerville MC, Rittmaster RS. The relationship between prostate inflammation and lower urinary tract symptoms: Examination of baseline data from the REDUCE trial. Eur Urol. 2007 Nov 20.
Northouse LL et al. Randomized clinical trial of a family intervention for prostate cancer patients and their spouses. Cancer. 2007 Dec 15; 110(12):2809-2818.
Okotie OT, Roehl KA, Han M, Loeb S, Gashti SN, Catalona WJ. Urology. 2007 Dec; 70(6):1117-1120.
Orsini N, Mantzoros CS, Wolk A. Association of physical activity with cancer incidence, mortality, and survival: A population-based study of men. British J Cancer. 2008 May 27; 98(11):1864-1869.
Peeters KC et al. The TME trial after a median follow-up of 6 years: Increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg. 2007 Nov; 246(5):693-701.
Press OA et al. Gender-related survival differences associated with EGFR polymorphisms in metastatic colon cancer. Cancer Research. 2008 Apr 18; 68(8):3037-3042.
Price MM, Hamilton RJ, Robertson CN, Butts MC, Freedland SJ. Body mass index, prostate-specific antigen, and digital rectal examination findings among participants in a prostate cancer screening clinic. Urology. 2008 Feb 9.
Rajinikanth A, Manoharan M, Soloway CT, Civantos FJ, Soloway MS. Trends in Gleason score: Concordance between biopsy and prostatectomy over 15 years. Urology. 2008 Feb 15.
Ream E et al. Supportive care needs of men living with prostate cancer in England: A survey. Brit J Cancer. 2008; 98:1903-1909.
Redman MW, Tangen CM, Goodman PJ, Lucia MS, Coltman Jr CA, Thompson IM. Finasteride does not increase the risk of high-grade prostate cancer: A bias-adjusted modeling approach. Cancer Prevention Research. 2008 May 18.
Roach III M et al. Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: Long-term results of RTOG 8610. JCO. 2008 Jan 2.
Roehrborn CG. The effects of Dutasteride, Tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2 year results from the CombAT study. J Urol. 2008 Feb; 179(2):616-621.
Sanda MG et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. NEJM. 2008 Mar 20; 358(12):1250-1261.
Sargeant AM et al. OSU-HDAC42, a histone deacetylase inhibitor, blocks prostate tumor progression in the transgenic adenocarcinomas of the mouse prostate model. Cancer Research. 2008 May 15; 68(10):3999-4009.
Scales CD et al. Predicting unilateral prostate cancer based on biopsy features: Implications for focal ablative therapy-results from the SEARCH database. J Urology. 2007 Oct; 178(4):1249-1252.
Scattoni V et al. Initial extended transrectal prostate biopsy – Are more prostate cancers detected with 18 cores than with 12 cores? J Urology. 2008 Apr; 179(4):1327-1331.
Seeram NP et al. Pomegranate Ellagitannin-Derived Metabolites Inhibit Prostate Cancer Growth and Localize to the Mouse Prostate Gland. J Agric Food Chem. 2007; 55(19):7732-7737.
Setlur SR et al. Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer. JNCI. 2008 June; 100(11):815-825
Shah JB, McKiernan JM, Elkin EP, Carroll PR, Meng MV. Prostate biopsy patterns in the CaPSURE database: Evolution with time and impact on outcome after prostatectomy. J Urol. 2008 Jan; 179(1):136-140.
Shah HN, Sodha HS, Kharodawala SJ, Khandkar AA, Hegde SS, Bansal MB. Influence of prostate size on the outcome of holmium laser enucleation of the prostate. BJU Int. 2008 Jan 24.
Shariat SF et al. Early postoperative plasma transforming growth factor-beta1 is a strong predictor of biochemical progression after radical prostatectomy. J Urol. 2008 Feb 21.
Shariat SF et al. Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkers. Clinical Cancer Research. 2008 June; 14(12):3785-3791.
Strom S, Yamamura Y, Forman MR, Pettaway CA, Barrera SL, DiGiovanni J. Saturated fat intake predicts biochemical failure after prostatectomy. Int J Cancer. 2008 Mar; 122(11):2581-2585.
Svatek RS, Lee JJ, Roehrborn CG, Lippman SM, Lotan Y. Cost-effectiveness of prostate cancer chemoprevention. Cancer. 2008 Jan 10.
Takahito H, Miyazaki AL, Tran CP, Reiter RE. Androgen receptor and invasion in prostate cancer. Cancer Res. 2008 Feb 15; 68(4):1128-1135.
Thall PF et al. Adaptive therapy for androgen-independent prostate cancer: A randomized selection trial of four regimens. J Natl Cancer Inst. 2007 Nov; 99(21):1613-1622.
Thomas G et al. Multiple loci identified in a genome wide association study of prostate cancer. Nature Genetics. 2008 Mar; 40(3):310-315.
Tomlins SA et al. The role of SPINK1 in ETS rearrangement-negative prostate cancers. Cancer Cell. 2008 June 10; 13(6):519-528.
Torkko KC et al. VDR and SRD5A2 polymorphisms combine to increase risk for prostate cancer in both non-Hispanic white and Hispanic white men. Clinical Cancer Research. 2008 May 15; 14(10):3223-3229.
Trock BJ et al. Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy. JAMA. 2008 June; 299(23):2760-2769.
Ulmert D et al. Long-term prediction of prostate cancer: Prostate-Specific Antigen (PSA) velocity is predictive but does not improve the predictive accuracy of a single PSA measurement 15 years or more before cancer diagnosis in a large, representative, unscreened population. J Clin Oncol. 2008 Feb 20; 26(6):835-841.
Ulmert D et al. Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: A case control study. BMC Medicine. 2008 Feb 15; 6:6.
Venkateswaran V et al. Association of diet-induced hyperinsulinemia with accelerated growth of prostate cancer (LNCaP) xenografts. J Natl Cancer Inst. 2007 Nov 27.
Wallace TA et al. Tumor immunobiological differences in prostate cancer between African-American and European-American men. Cancer Research. 2008 Feb 1; 68(3):927-936.
Weber BA, Roberts BL, Chumbler NR, et al. Urinary, sexual, and bowel dysfunction and bother after radical prostatectomy. Urol Nurs; 2007 Dec; 27(6):527-33.
Weight CJ, Klein EA, Jones JS. Androgen deprivation falls as orchiectomy rates rise after changes in reimbursement in the U.S. Medicare population. Cancer. 2008 Apr 7.
Weiss JM et al. Endogenous sex hormones and the risk of prostate cancer: A prospective study. Int J Cancer. 2008 Jan 2.
Yu J et al. Integrative genomics analysis reveals silencing of beta-andrenergic signaling by polycomb in prostate cancer. Cancer Cell. 2007 Nov; 12(5):419-431.
Zheng SL et al. Cumulative association of five genetic variants with prostate cancer. NEJM. 2008 Jan 16.
The Male Role in Reproductive Health
Armitage JN, Sibanda N, Cathcart PJ, Emberton M, van der Meulen JHP. Mortality in men admitted to hospital with acture urinary retention: Database analysis. BMJ. 2007 Nov 8.
Bentley RA, Wahl J, Price TD, Atkinson TC. Isotopic signatures and hereditary traits: Snapshot of a Neolithic community in Germany. Antiquity. 2008 June; 82(316):290-304.
Brugts MP et al. Low circulating IGF-I bioactivity in elderly men is associated with increased mortality. J Clin Endo & Metab. 2008 Apr 15.
Chen X-K, Wen SW, Krewski D, Fleming N, Yang Q, Walker MC. Paternal age and adverse birth outcomes: Teenager or 40+, who is at risk? Hum Reprod. 2008 Feb 6.
Choi S-K, Yoon S-R, Calabrese P, Arnheim N. A germ-line-selective advantage rather than an increased mutation rate can explain some unexpectedly common human disease mutations. PNAS. 2008 July 16.
Cinar A et al. Cluster analysis and lower urinary tract symptoms in men: Findings from the Boston Area Community Health Survey. BJU Int. 2008 May; 101(10):1247-1256.
Diep BA et al. Emergency of Multidrug-Resistant, community-associated, Methicillin-Resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann Intern Med. 2008 Jan 14.
Emmelot-Vonk MH et al. Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men. JAMA. 2008 Jan 2; 299(1):39-52.
Gao X et al. Erectile function and risk of Parkinson’s disease. Am J Epidemiol. 2007 Dec 15; 166(12):1446-1450.
Giles DC, Close J. Exposure to ‘lad magazines’ and drive for muscularity in dating and non-dating young men. Personality and Individual Differences. 2008 May; 44(7):1610-1616.
Grossmann M et al. Low testosterone levels are common and associated with insulin resistance in men with diabetes. J Clin End & Metab. 2008 Mar 4.
Hall SA et al. Treatment of symptomatic androgen deficiency: Results from the Boston Area Community Health Survey. Arch Intern Med. 2008; 168(10):1070-1076.
Hinchley G. Is infant male circumcision an abuse of the rights of the child? Yes. BMJ. 2007 Dec 8; 335(7631):1180.
Khaw KT et al. Endogenous testosterone and mortality due to all causes, cardiovascular disease and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study. Ciculation. 2007 Nov 26.
Kind J et al. Genome-wide analysis reveals MOF as a key regulator of dosage compensation and gene expression in Drosophila. Cell. 2008 May 30; 133:813-828.
Klein MI et al. Differential gender response to respiratory infections and to the protective effect of breast milk in preterm infants. Pediatrics. 2008 June 6; 121(6):e1510-1516.
Lydon JE, Menzies-Toman D, Burton K, Bell C. If-then contingencies and the differential effects of the availability of an attractive alternative on relationship maintenance for men and women. J Personality and Soc Psych. 2008 July; 95(1):50-65.
Osvaldo PA, Yeap BB, Hankey GJ, Jamrozik K, Flicker L. Low free testosterone concentration as a potentially treatable cause of depressive symptoms in older men. Arch Gen Psychiatry. 2008 Mar; 65(3):283-289.
Pang P-C et al. Expression of bisecting type and lewis x/lewis y terminated N-glycans on human sperm. J Bio Chem. 2007 Dec 14; 282(50):36593-36602.
Patrick K. Is infant male circumcision an abuse of the rights of the child? No. BMJ. 2007 Dec 8; 335(7631):1180.
Procopio M. Intrauterine hormonal environment and risk of developing anorexia nervosa. Arch Gen Psychiatry. 2007 Dec; 64(12):1402-1407.
Reid RJ et al. Intimate partner violence among men: Prevalence, chronicity, and health effects. Am J Prev Med. 2008 June; 34(6):478-485.
Rosen RC et al. Beyond the cluster: Methodological and clinical implications in the Boston Area Community Health Survey and EPIC studies. BJU Int. 2008 May; 101(10):1274-1278.
Savic I, Lindström P. PET and MRI show differences in cerebral asymmetry and functional connectivity between homo – and heterosexual subjects. Proc Natl Acad Sci. 2008 June 16.
Smith JA, Braunack-Mayer A, Wittert G, Warin M. “It’s sort of like being a detective”: Understanding how Australian men self-monitor their health prior to seeking help. BMC Health Services Research. 2008 Mar 14; 8:56.
Stark MJ, Clifton VL, Wright IMR. Sex-specific differences in peripheral microvascular blood flow in preterm infants. Pediatric Research. 2008 Apr; 63(4):415-419.
White MA, Maatman TJ. Comparative analysis of effectiveness of two local anesthetic techniques in men undergoing no-scalpel vasectomy. Urology. 2007 Dec; 70(6):1187-1189.
Sex, Sexuality & Sexual Health
Bellis MA et al. Sexual uses of alcohol and drugs and the associated health risks: A cross sectional study of young people in nine European cities. BMC Public Health. 2008; 8:155.
Ching-Wan Ma R et al. Erectile dysfunction predicts coronary heart disease in Type 2 diabetes. J Am Coll Cardiol. 2008, May 27; 51:2045-2050.
Dai H et al. The evolution of courtship behaviors through the origination of a new gene in Drosophila. PNAS. 2008 May 27; 105)21):7478-7483.
Gazzaruso C, Solerte SB, Pujia A, et al. Erectile Dysfunction as a Predictor of Cardiovascular Events and Death in Diabetic Patients With Angiographically Proven Asymptomatic Coronary Artery Disease: A Potential Protective Role for Statins and 5-Phosphodiesterase Inhibitors. J Am Coll Cardiol 2008 51: 2040-2044.
Janssen E, McBride KR, Yarber W, Hill BJ, Butler SM. Factors that influence sexual arousal in men: A focus group study. Arch Sex Behav. 2008 Apr; 37(2):1573-2800.
Kigozi G et al. The effect of male circumcision on sexual satisfaction and function, results from a randomized trial of male circumcision for human immunodeficiency virus prevention, Rakai, Uganda. BJU Int. 2008 Jan; 101(1):65-70.
Långström N, Rahman Q, Carlström E, Lichtenstein P. Genetic and environmental effects on same-sex sexual behavior: A population study of twins in Sweden. Arch Sex Behav. 2008 June 7.
Ma R, So W, Yang X, et al. Erectile Dysfunction Predicts Coronary Heart Disease in Type 2 Diabetes. J Am Coll Cardiol 2008 51: 2045-2050.
Mercer CH, Fenton KA, Wellings K, Copas AJ, Erens B, Johnson AM. Sex partner acquisition while overseas: Results from a British national probability survey. Sex Transm Infect. 2007 Nov 8.
Namiki S et al. Sexual function reported by Japanese and American men. J Urol. 2008 Jan; 179(1):245-9.
Van den Bergh B, Dewitte S, Warlop L. Bikinis instigate generalized impatience in intertemporal choice. J Consumer Research. 2008 June; 35(1):85-97.
Celum C et al. Effect of acyclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: A randomized, double-blind, placebo-controlled trial. Lancet. 2008 June; 371(9630):2109-2119.
Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for Human Papillomavirus-related and –unrelated oral squamous cell carcinomas in the United States. J Clinical Oncology. 2008 Feb 1; 26(4):612-619.
Coleman CL, Ball K. Determinants of perceived barriers to condom use among HIV-infected middle-aged and older African-American men. J Adv Nur. 2007 Nov; 60(4)368-376.
Darbes LA, Crepaz NB, Lyles CB, Kennedy GC, Rutherford GC. The efficacy of behavioral interventions in reducing HIV risk behaviors and incident sexually transmitted diseases in heterosexual African Americans. AIDS. 2008 June 19; 22(10):1177-1194.
Horvath KJ, Rosser BR, Remafedi G. Sexual risk taking among young internet-using men who have sex with men. Am J Public Health. 2008 Apr 29.
Jaffe HW, Valdiserri RO, De Cock KM. The reemerging HIV/AIDS epidemic in men who have sex with men. JAMA. 2007 Nov 28; 298(20):2412-2414.
Kigozi G et al. The safety of adult male circumcision in HIV-infected and uninfected men in Rakai, Uganda. PLoS. 2008 June; 5(6):e116.
Liss M, Osann K, Ornstein D. Positive surgical margins during robotic radical prostatectomy: A contemporary analysis of risk factors. BJU Int. 2008 Apr 24.
Münch J et al. Semen-derived amyloid fibrils drastically enhance HIV infection. Cell. 2007 Dec 14; 131(6):1059-1071.
Nyitray A et al. Prevalence of and risk factors for anal human papillomavirus infection in heterosexual men. J Infect Dis. 2008 Jun 15; 197(12):1676-1684.
Pask AJ, McInnes KJ, Webb DR, Short RV. Topical oestrogen keratinizes the human foreskin and may help prevent HIV infection. PLoS One. 2008 June 4; 3(6):e2308.
Wilson DP, Coplan PM, Wainberg MA, Blower SM. The paradoxical effects of using antiretroviral-based microbicides to control HIV epidemics. Proc Natl Acad Sci USA. 2008 Jul 7.
